Logo of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)
Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) shareholders will vote on the board’s recommendation on paying cash dividends at 15% of capital, or SAR 1.5 per share, for the second half of 2023, during the extraordinary general meeting (EGM), to be held on June 4, according to a Tadawul statement.
Dividend Details (H2 2023)
Current capital
SAR 700 mln
Number of shares
70 mln
Dividend
SAR 105 mln
Percentage of capital
15% (SAR 1.5 per share)
Record date
Shareholders of record and those registered with Edaa by the close of the second trading day following the record date
Payment date
To be set later
2023 Dividends
Total dividend
SAR 175 mln
Percentage of capital
25% (SAR 2.5 per share)
Shareholders will also vote on authorizing the board of directors to distribute interim dividends on a quarterly or semi-annually basis for 2024.
>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Argaam EN – https://www.argaam.com/en/article/articledetail/id/1727686
